Preliminary study of guard hair morphology in four dog breeds.

BACKGROUND: Morphological differences between mammalian hair types are useful for species distinction. Differences in animal hair structure are observed between species, whereas there may be breed differences within a species. HYPOTHESIS: Guard hair structure may vary between different dog breeds. ANIMALS: Hair samples were collected from 73 dogs of four breed types (wire-haired Dachshund, Labrador retriever, German shepherd dog and Yorkshire terrier). METHODS: Hair was measured and analysed by scanning electron microscopy. The following were evaluated: hair thickness; medulla to hair cross-sectional area ratio; scale density, pattern and margins; and medulla shape, composition and structure. RESULTS: There were significant differences in all measured parameters between breeds. CONCLUSIONS AND CLINICAL IMPORTANCE: These study findings may be useful for the study of classifying dog breeds and for forensic identification of a dog breed through hair sampling.

In vivo and ex vivo evaluation of cosmetic properties of seedcakes.

The seedcakes are a potential source of natural bioactive substances: antioxidants, protein, and carbohydrates. Thus, they may scavenge free radicals and have an effect on the stratum corneum hydration and epidermal barrier function. The aim of the study was to evaluate the in vivo and ex vivo properties of emulsions with the seedcake extracts using the pH meter, corneometer, tewameter, methyl nicotinate model of micro-inflammation in human skin, and tape stripping of the stratum corneum. The in vivo and ex vivo studies showed that the emulsions with Oenothera biennis, Borago officinalis, and Nigella sativa seedcake extracts have anti-inflammatory and antioxidant activity. The 6-week topical application of the emulsions with the B. officinalis and N. sativa seedcakes significantly reduced skin irritation and influenced the improvement of the skin hydration and epidermal barrier function compared with placebo. The seedcakes due to their antioxidant and anti-inflammatory activities have potential application in anti-aging, moisturizing, mitigating, and protective cosmetics.

Influence of polyphenols on the physiological processes in the skin.

In the last decade antioxidants from a group of polyphenols have been proposed as one of the most effective functional ingredients of anti-ageing properties that counteract the effects of oxidative damage to the skin. It has been shown that the use of polyphenols affects skin protection and mitigates inflammatory conditions of the skin. Numerous studies have confirmed that polyphenols by neutralizing free radicals, antioxidant activity and by their ability to chelate ions of transition metals can effectively reduce the level of nonprotein inflammatory mediators. The biological activity of polyphenols in the skin is primarily determined by their physicochemical properties and the ability to overcome the epidermal barrier as they try to reach appropriate receptors. This study reviews literature on the effects of polyphenols relating to the physiological processes in the skin and role of the major plant polyphenols in cosmetology and dermatology.

Methods for evaluation of cosmetic antioxidant capacity.

The skin as the largest part of human body is one of the main targets for ultraviolet radiation, environmental pollution, toxic chemicals and some metal ions, which share responsibility for the formation of free radicals. The resulting free radicals, both oxygen and nitrogen species are one of the main causes of aging due to impaired regulation of cell respiratory metabolism involving incomplete oxygen reduction in mitochondria and production a superoxide anion, hydroxyl radicals et al. In modern cosmetology to minimize the adverse effects of free radicals, antioxidants, which inhibit free radical reactions, mainly autoxidation processes are used. Currently, not only many cosmetic products containing antioxidants are available, but a large diversity of methods for determination of cosmetics antioxidant activity is also accessible. These methods can be divided into three main groups: in vitro, in vivo, and ex vivo as reported herein. Due to lack of standardization and validation it is necessary to use a variety of methods as well as conditions for those purposes, which are presented to the context.

Should we supplement zinc in COVID-19 patients? Evidence from a meta-analysis.

INTRODUCTION: Preliminary retrospective reports showed that zinc supplementation may decrease mortality in patients with COVID-19, postulating the potential therapeutic efficacy of zinc in the management of the disease. OBJECTIVES: We sought to summarize the studies published to date regarding the antiviral activity of zinc in patients with COVID-19. PATIENTS AND METHODS: A meta-analysis was performed to compare the outcomes of hospitalized patients receiving zinc supplementation and those treated with standard care. The primary outcome was survival to hospital discharge. Secondary outcomes were in-hospital mortality and length of stay in hospital or intensive care unit (ICU). RESULTS: Data relating to 1474 patients included in 4 studies were analyzed. Survival to hospital discharge was 56.8% in the zinc group compared with 75.9% in the nonzinc group (P = 0.88). In-hospital mortality was 22.3% in the zinc group compared with 13.6% in the standard care group (P = 0.16). The mean (SD) length of hospital stay was 7.7 (3.7) days in the zinc group and 7.2 (3.9) days in the standard treatment group (P <⁠0.001). The mean (SD) length of ICU stay was 4.9 (1.7) days in the zinc group and 5.8 (1.9) days in the standard care group (P = 0.009). CONCLUSIONS: Zinc supplementation did not have any beneficial impact on the course of COVID-19 evaluated as survival to hospital discharge and in-hospital mortality. The zinc-supplemented group had longer hospital stay despite shorter ICU stay. At present, there are no evidence-based data to support routine zinc supplementation in patients with COVID-19.

Characteristics and outcomes of in-hospital cardiac arrest in COVID-19. A systematic review and meta-analysis.

BACKGROUND: The purpose herein, was to perform a systematic review of interventional outcome studies in patients with in-hospital cardiac arrest before and during the coronavirus disease 2019 (COVID-19) pandemic period. METHODS: A meta-analysis was performed of publications meeting the following PICOS criteria: (1) participants, patients > 18 years of age with cardiac arrest due to any causes; (2) intervention, cardiac arrest in COVID-19 period; (3) comparison, cardiac arrest in pre-COVID-19 period; (4) outcomes, detailed information for survival; (5) study design, randomized controlled trials, quasi-randomized or observational studies comparing cardiac arrest in COVID-19 and pre-COVID-19 period for their effects in patients with cardiac arrest. RESULTS: Survival to hospital discharge for the pre-pandemic and pandemic period was reported in 3 studies (n =1432 patients) and was similar in the pre-pandemic vs. the pandemic period, 35.6% vs. 32.1%, respectively (odds ratio [OR] 1.72; 95% confidence interval [CI] 0.81-3.65; p = 0.16; I2 = 72%). Return of spontaneous circulation was reported by all 4 studies and were also similar in the pre and during COVID-19 periods, 51.9% vs. 48.7% (OR 1.27; 95% CI 0.78-2.07; p = 0.33; I2 = 71%), respectively. Pooled analysis of cardiac arrest recurrence was also similar, 24.9% and 17.9% (OR 1.60; 95% CI 0.99-2.57; p = 0.06; I2 = 32%) in the pre and during COVID-19 cohorts. Survival with Cerebral Performance Category 1 or 2 was higher in pre vs. during pandemic groups (27.3 vs. 9.1%; OR 3.75; 95% CI 1.26-11.20; p = 0.02). Finally, overall mortality was similar in the pre vs. pandemic groups, 65.9% and 67.2%, respectively (OR 0.67; 95% CI 0.33-1.34; p = 0.25; I2 = 76%). CONCLUSIONS: Compared to the pre-pandemic period, in hospital cardiac arrest in COVID-19 patients was numerically higher but had statistically similar outcomes.

Flavonoids as components of biologically active cosmeceuticals.

Flavonoids are multi-active components used in common cosmetics primarily for antioxidant and soothing actions. Despite this, their multi-active properties are far from being fully used. It is well known that many flavonoids provide protection from telangiectasias and petechias caused by ruptured blood vessels. Thus, the notion of a "strengthening" effect of these compounds on blood vessel walls is common. The activity of flavonoids on skin blood vessels is complex. Three main components of their activity can be distinguished: blood vessel protection, platelet aggregation prevention, and capillary permeability decrease. Each of these components is realized with the participation of several mechanisms differing on the types of receptors that the flavonoids affect. Some of them consist of a direct action on the enzymes responsible for the synthesis of substances of tissue hormone character, such as thromboxanes, histamine, or platelet activating factor. The mechanisms based on less or more indirect activity can also be met. At least 11 points for activity can be distinguished among flavonoids' actions on blood vessels.